Allianz Asset Management GmbH

Position in DNA — Ginkgo Bioworks Holdings, Inc.

CIK 1535323 MUNICH, 2M

Position in DNA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$7,787,258

+$3,493,095 QoQ

Shares Held

785,798

+12.2% QoQ

Ownership

1.17%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#11

of 183 holders

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Allianz Asset Management GmbH holds $690,566,615 across 64 Biotechnology names. DNA ranks #15 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	327,683	$204,323,456
2	JAZZ	Jazz Pharmaceuticals plc	564,696	$136,074,794
3	MRNA	Moderna, Inc.	989,897	$69,322,486
4	EXEL	Exelixis, Inc.	853,093	$46,416,787
5	APGE	Apogee Therapeutics, Inc.	179,500	$23,825,035
6	BMRN	Biomarin Pharmaceutical Inc	400,036	$22,890,059
7	FTRE	Fortrea Holdings Inc.	1,127,337	$19,615,663
8	ACAD	Acadia Pharmaceuticals Inc	706,664	$17,878,599

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,787,258	785,798	+12.2%	Shares	Defined	2026-08-14
2026-03-31	$4,294,163	700,516	+55.7%	Shares	Defined	2026-05-11
2025-12-31	$3,737,738	449,788	+134.1%	Shares	Defined	2026-02-11
2025-09-30	$2,801,692	192,160	-86.2%	Shares	Defined	2025-11-04
2024-03-31	$1,610,615	1,388,462	+24.7%	Shares	Defined	2024-05-14
2023-12-31	$1,881,172	1,113,120	0.0%	Shares	Defined	2024-02-12
2023-09-30	$2,014,747	1,113,120	0.0%	Shares	Defined	2023-11-13
2023-06-30	$2,070,403	1,113,120	+21.9%	Shares	Defined	2023-08-14
2023-03-31	$1,214,449	913,120	+35.0%	Shares	Defined	2023-05-11
2022-12-31	$1,142,848	676,242	0.0%	Shares	Defined	2023-02-13
2022-09-30	$2,109,875	676,242	—	Shares	Defined	2022-11-08
No filing history on record for this holder in this stock.